# Ardelyx clinical trials: 29 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with Ardelyx as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ardelyx: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ardelyx

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 2, 2026 | NCT07382167 | A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults | Ardelyx | Phase 3 | Recruiting | Chronic Idiopathic Constipation (CIC) | 692 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382167) |
| August 14, 2024 | NCT06553547 | 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to \<12 Yrs | Ardelyx | Phase 2 | Completed | Irritable Bowel Syndrome With Constipation (IBS-C) | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06553547) |
| January 12, 2024 | NCT06203444 | An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females | Ardelyx | Phase 1 | Completed | Lactation | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06203444) |
| June 15, 2023 | NCT05905926 | Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C | Ardelyx | Phase 3 | Enrolling by invitation | Irritable Bowel Syndrome With Constipation (IBS-C) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05905926) |
| December 8, 2022 | NCT05643534 | Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years | Ardelyx | Phase 3 | Completed | Irritable Bowel Syndrome With Constipation (IBS-C) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05643534) |
| March 4, 2021 | NCT04780841 | A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia | Ardelyx | Phase 2 | Completed | Hyperkalemia | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04780841) |
| September 16, 2020 | NCT04549597 | Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia | Ardelyx | Phase 4 | Completed | Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04549597) |
| June 18, 2019 | NCT03988920 | A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP | Ardelyx | Phase 4 | Completed | Hyperphosphatemia, End Stage Renal Disease | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03988920) |
| January 31, 2019 | NCT03824587 | Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy | Ardelyx | Phase 2/3 | Completed | Hyperphosphatemia | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03824587) |
| February 9, 2018 | NCT03427125 | A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis | Ardelyx | Phase 3 | Completed | Hyperphosphatemia | 1,559 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03427125) |
| January 11, 2017 | NCT03018067 | A Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of Hyperkalemia | Ardelyx | Phase 2 | Terminated | Hyperkalemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03018067) |
| June 30, 2016 | NCT02819687 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers | Ardelyx | Phase 1 | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02819687) |
| June 10, 2016 | NCT02796131 | Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers | Ardelyx | Phase 1 | Completed | Healthy | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02796131) |
| April 5, 2016 | NCT02727751 | A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C | Ardelyx | Phase 3 | Completed | Constipation Predominant Irritable Bowel Syndrome | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02727751) |
| February 19, 2016 | NCT02686138 | A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C | Ardelyx | Phase 3 | Completed | Constipation Predominant Irritable Bowel Syndrome | 593 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02686138) |
| February 5, 2016 | NCT02675998 | An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) | Ardelyx | Phase 3 | Completed | Hyperphosphatemia | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02675998) |
| December 4, 2015 | NCT02621892 | A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C | Ardelyx | Phase 3 | Completed | Constipation Predominant Irritable Bowel Syndrome | 606 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02621892) |
| January 27, 2015 | NCT02346890 | A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722 | Ardelyx | Phase 1 | Completed | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02346890) |
| September 26, 2014 | NCT02249936 | A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations | Ardelyx | Phase 1 | Completed | Healthy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02249936) |
| August 27, 2014 | NCT02226783 | D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects | Ardelyx | Phase 1 | Completed | Healthy Volunteers Food Interaction Study | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02226783) |
| June 27, 2014 | NCT02176252 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects | Ardelyx | Phase 1 | Completed | Healthy Volunteer | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02176252) |
| May 16, 2014 | NCT02140281 | To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers | Ardelyx | Phase 1 | Completed | Healthy Volunteers | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02140281) |
| May 16, 2014 | NCT02140268 | To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers | Ardelyx | Phase 1 | Completed | Healthy Volunteers | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02140268) |
| March 7, 2014 | NCT02081534 | Dose Finding Study to Treat High Phosphate Levels in the Blood. | Ardelyx | Phase 2 | Completed | Hyperphosphatemia | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02081534) |
| February 14, 2014 | NCT02063386 | AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study | Ardelyx | Phase 1 | Completed | Healthy Volunteers | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02063386) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 10 |
| Phase 2 | 7 |
| Phase 2/3 | 2 |
| Phase 3 | 8 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 26 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hyperphosphatemia | 6 |
| Kidney Failure, Chronic | 3 |
| Renal Insufficiency, Chronic | 2 |
| Hyperkalemia | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Albuminuria | 1 |
| Breast Feeding | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Health insurance offices in the United States](https://specstream.ai/data/businesses/health-insurance-offices/united-states)
- [Tenant and eviction law firms in the United States](https://specstream.ai/data/businesses/tenant-and-eviction-law-firms/united-states)
- [Environmental abatement companies in the United States](https://specstream.ai/data/businesses/environmental-abatement-companies/united-states)
- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Computer wholesalers in the United States](https://specstream.ai/data/businesses/computer-wholesalers/united-states)
- [Patio cover companies in the United States](https://specstream.ai/data/businesses/patio-cover-companies/united-states)
